Literature DB >> 19816149

Advances in personalized therapeutics in non-small cell lung cancer: 4q12 amplification, PDGFRA oncogene addiction and sunitinib sensitivity.

Charles Swanton1, Rebecca A Burrell.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19816149     DOI: 10.4161/cbt.8.21.9886

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


× No keyword cloud information.
  2 in total

Review 1.  Oncogene addiction in gliomas: implications for molecular targeted therapy.

Authors:  Wei Yan; Wei Zhang; Tao Jiang
Journal:  J Exp Clin Cancer Res       Date:  2011-05-17

2.  Molecular genetic studies on EGFR, KRAS, BRAF, ALK, PIK3CA, PDGFRA, and DDR2 in primary pulmonary adenoid cystic carcinoma.

Authors:  Zhen Huo; Huanwen Wu; Shanqing Li; Zhiyong Liang
Journal:  Diagn Pathol       Date:  2015-09-15       Impact factor: 2.644

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.